What do systematic reviews say?

Antifibrinolytic therapy - locally-applied tranexamic acid (TXA) mouthwash/solution (SoF eligibility: TXA or EACA; all included trials used topical TXA) vs placebo or usual care

• Tranexamic acid for percutaneous nephrolithotomy 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 400 participants
  Moderate